Document is current
Any future updates will be listed below
-
Authors
Salavati, Arman https://orcid.org/0009-0008-5557-0023
van der Wilt, C. Nina https://orcid.org/0009-0008-9770-6523
Calore, Martina https://orcid.org/0000-0003-4751-1476
van Es, René https://orcid.org/0000-0001-9950-4388
Rampazzo, Alessandra https://orcid.org/0000-0003-3884-8843
van der Harst, Pim https://orcid.org/0000-0002-2713-686X
van Steenbeek, Frank G. https://orcid.org/0000-0001-5460-6540
van Tintelen, J. Peter https://orcid.org/0000-0003-3854-6749
Harakalova, Magdalena https://orcid.org/0000-0002-7293-1029
te Riele, Anneline S. J. M. https://orcid.org/0000-0003-1115-6193
-
Funding
Funding for this research was provided by:
IMPACT project from the EU Horizon Pathfinder program (101115536, 101115536, 101115536, 101115536, 101115536, 101115536, 101115536)
- License Information
-
More Information
Article History
Accepted: 30 September 2024
First Online: 11 December 2024
Declarations
:
: Arman Salavati, Nina van der Wilt, Martina Calore, Alessandra Rampazzo, Pim van der Harst, Frank van Steenbeek, and Magdalena Harakalova declare that they have no conflict of interest. Anneline te Riele is a consultant for Tenaya Therapeutics and BioMarin outside of the scope of the current work. Peter van Tintelen is a consultant for BioMarin outside the scope of the current work. René van Es is co-founder and shareholder of Cordys Analytics, is supported by grants/contracts from Abbott, ICC Europe, Pfizer, Sanofi and NWO.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
